Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19 Pt 2
|
pubmed:dateCreated |
1998-9-25
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
411-3
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:9645095-Animals,
pubmed-meshheading:9645095-Diagnosis, Differential,
pubmed-meshheading:9645095-G(M2) Activator Protein,
pubmed-meshheading:9645095-G(M2) Ganglioside,
pubmed-meshheading:9645095-Gangliosidoses,
pubmed-meshheading:9645095-Humans,
pubmed-meshheading:9645095-Mutation,
pubmed-meshheading:9645095-Prognosis,
pubmed-meshheading:9645095-Proteins
|
pubmed:year |
1998
|
pubmed:articleTitle |
[GM2 activator protein deficiency (AB variant form of GM2 gangliosidosis)].
|
pubmed:affiliation |
Department of Neuropsychiatry, Ehime University School of Medicine.
|
pubmed:publicationType |
Journal Article,
Review
|